Detalhe da pesquisa
1.
Poorly Differentiated Hepatocellular Carcinoma Cells Avoid Apoptosis by Interacting with T Cells via CD40-CD40L Linkage.
Am J Pathol
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548267
2.
Soluble Immune Checkpoint Protein CD27 Is a Novel Prognostic Biomarker of Hepatocellular Carcinoma Development in Hepatitis C Virus-Sustained Virological Response Patients.
Am J Pathol
; 192(10): 1379-1396, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963463
3.
Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohort.
J Viral Hepat
; 30(5): 374-385, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36583600
4.
Direct-acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment.
J Viral Hepat
; 29(1): 52-59, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34695288
5.
Sofosbuvir-velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in Japan.
Hepatol Res
; 52(10): 833-840, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802063
6.
Identification of microRNA-96-5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma.
Hepatol Res
; 52(1): 93-104, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34038612
7.
Outcome of nucleos(t)ide analog intervention in patients with preventive or on-demand therapy for hepatitis B virus reactivation.
J Med Virol
; 93(6): 3679-3687, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32940921
8.
Cure With Interferon-Free Direct-Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma From Both East and West.
Hepatology
; 71(6): 1910-1922, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31610027
9.
Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas.
Oncology
; 99(3): 186-191, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33032274
10.
Postoperative direct-acting antiviral treatment after liver resection in patients with hepatitis C virus-related hepatocellular carcinoma.
Hepatol Res
; 51(11): 1102-1114, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476874
11.
Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis C.
J Gastroenterol Hepatol
; 36(1): 217-224, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32453907
12.
Lifestyles Associated with Prognosis After Eradication of Hepatitis C Virus: A Prospective Cohort Study in Japan.
Dig Dis Sci
; 66(6): 2118-2128, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32720018
13.
Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy.
Int J Mol Sci
; 22(3)2021 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33535672
14.
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication.
Clin Infect Dis
; 71(11): 2840-2848, 2020 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31777940
15.
Surgical outcomes for hepatocellular carcinoma detected after hepatitis C virus eradiation by direct-acting antivirals.
J Surg Oncol
; 122(8): 1543-1552, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856301
16.
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients.
Ann Hepatol
; 19(4): 367-372, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32444247
17.
Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C.
Int J Mol Sci
; 21(12)2020 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32630450
18.
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.
J Hepatol
; 71(3): 473-485, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31096005
19.
Switching to tenofovir disoproxil fumarate vs continuing treatment in patients with chronic hepatitis B who maintain long-term virological response to entecavir therapy: A randomized trial.
J Med Virol
; 91(7): 1295-1300, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30815880
20.
Intention-to-treat assessment of glecaprevir + pibrentasvir combination therapy for patients with chronic hepatitis C in the real world.
Hepatol Res
; 49(12): 1365-1373, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31323165